ARM 37.14.552. TRANSPORTATION: PREPARATION OF MATERIAL

(1) For the purposes of this rule, a licensee who transports his own licensed material as a private carrier is considered to have delivered such material to a carrier for transport. (2) No licensee shall deliver any radioactive material to a carrier for transport, unless: (a) the licensee complies with the applicable requirements of the regulations, appropriate to the mode of transport, of the US department of transportation insofar as such regulations relate to the packaging of radioactive material, and to the monitoring, marking and labeling of those packages; (b) the licensee has established procedures for opening and closing packages in which radioactive material is transported to provide safety and to assure that, prior to the delivery to a carrier for transport, each package is properly closed for transport; and (c) prior to delivery of a package to a carrier for transport, the licensee shall assure that any special instructions needed to safely open the package are sent to or have been available to the consignee. (3) Section (2) of this rule shall not apply to the transportation of licensed material, or to the delivery of licensed material to a carrier for transport, where such transportation is subject to the regulations of the US department of transportation or the US postal service. SCHEDULE A EXEMPT CONCENTRATIONS Element (atomic number) Isotope Column I Gas Concentration µ Ci/ml 1 Column II Liquid & Solid Concentration µ Ci/ml 2 Antimony (51) Argon (18) Sb-122 Sb-124 Sb-125 Ar-37 Ar-41 1x10 -3 4x10 -7 3x10 -4 2x10 -4 1x10 -3 Arsenic (33) As-73 As-74 As-76 As-77 5x10 -3 5x10 -4 2x10 -4 8x10 -4 Barium (56) Beryllium (4) Bismuth (83) Ba-131 Ba-140 Be-7 Bi-206 2x10 -3 3x10 -4 2x10 -2 4x10 -4 Bromine (35) Cadmium (48) Br-82 Cd-109 Cd-115m Cd-115 4x10 -7 3x10 -3 2x10 -3 3x10 -4 3x10 -4 Calcium (20) Carbon (6) Cerium (58) Ca-45 Ca-47 C-14 Ce-141 Ce-143 Ce-144 1x10 -6 9x10 -5 5x10 -4 8x10 -3 9x10 -4 4x10 -4 1x10 -4 Cesium (55) Chlorine (17) Cs-131 Cs-134m Cs-134 Cl-38 9x10 -7 2x10 -2 6x10 -2 9x10 -5 4x10 -3 Chromium (24) Cobalt (27) Copper (29) Dysprosium (66) Cr-51 Co-57 Co-58 Co-60 Cu-64 Dy-165 Dy-166 2x10 -2 5x10 -3 1x10 -3 5x10 -4 3x10 -3 4x10 -3 4x10 -4 __________ 1 Values are given in Column I only for those materials normally used as gases. 2 µ C1/gm for solids. Element (atomic number) Isotope Column I Gas Concentration µ Ci/ml 1 Column II Liquid & Solid Concentration µ Ci/ml 2 Erbium (68) Europium (63) Er-169 Er-171 Eu-152 Eu-155 6x10 -4 9x10 -4 1x10 -3 (Tr=9.2 h) 2x10 -3 Fluorine (9) Gadolinium (64) F-18 Gd-153 Gd-159 2x10 -6 8x10 -3 2x10 -3 8x10 -4 Gallium (31) Germanium (32) Gold (79) Ga-72 Ge-71 Au-196 Au-198 Au-199 4x10 -4 2x10 -2 2x10 -3 5x10 -4 2x10 -3 Hafnium (72) Hydrogen (1) Indium (49) Hf-181 H-3 In-113m In-114m 5x10 -6 7x10 -4 3x10 -2 1x10 -2 2x10 -4 Iodine (53) I-126 I-131 I-132 I-133 I-134 3x10 -9 3x10 -9 8x10 -8 1x10 -8 2x10 -7 2x10 -5 2x10 -5 6x10 -4 7x10 -5 1x10 -3 Iridium (77) Iron (26) Ir-190 Ir-192 Ir-194 Fe-55 Fe-59 2x10 -3 4x10 -4 3x10 -4 8x10 -3 6x10 -4 Krypton (36) Lanthanum (57) Lead (82) Lutetium (71) Kr-85m Kr-85 La-140 Pb-203 Lu-177 1x10 -6 3x10 -6 2x10 -4 4x10 -3 1x10 -3 Manganese (25) Mercury (80) Molybdenum (42) Mn-52 Mn-54 Mn-56 1x10 -3 Hg-197m Hg-197 Hg-203 Mo-99 3x10 -4 1x10 -3 1x10 -3 2x10 -3 3x10 -3 2x10 -4 2x10 -3 __________ 1 Values are given in Column I only for those materials normally used as gases. 2 µ C1/gm for solids. Element (atomic number) Isotope Column I Gas Concentration µ Ci/ml 1 Column II Liquid & Solid Concentration µ Ci/ml 2 Neodymium (60) Nd-147 Nd-149 6x10 -4 3x10 -3 Nickel (28) Ni-65 1x10 -3 Niobium (Columbium) (41) Nb-95 Nb-97 1x10 -3 9x10 -3 Osmium (76) Os-185 Os-191m Os-191 Os-193 7x10 -4 3x10 -2 2x10 -3 6x10 -4 Palladium (46) Pd-103 Pd-109 3x10 -3 9x10 -4 Phosphorus (15) P-32 2x10 -4 Platinum (78) Pt-191 Pt-193m Pt-197m Pt-197 1x10 -3 1x10 -2 1x10 -2 1x10 -3 Potassium (19) K-42 3x10 -3 Praseodymium (59) Pr-142 Pr-143 3x10 -4 5x10 -4 Promethium (61) Pm-147 Pm-149 2x10 -3 4x10 -4 Rhenium (75) Re-183 Re-186 Re-188 6x10 -3 9x10 -4 6x10 -4 Rhodium (45) Rh-103m Rh-105 1x10 -1 1x10 -3 Rubidium (37) Rb-86 7x10 -4 Ruthenium (44) Ru-97 Ru-103 Ru-105 Ru-106 4x10 -3 8x10 -4 1x10 -3 1x10 -4 Samarium (62) Sm-153 8x10 -4 Scandium (21) Sc-46 Sc-47 Sc-48 4x10 -4 9x10 -4 3x10 -4 Selenium (34) Se-75 3x10 -3 Silicon (14) Si-31 9x10 -3 __________ 1 Values are given in Column I only for those materials normally used as gases. 2 µ C1/gm for solids. Element (atomic number) Isotope Column I Gas Concentration µ Ci/ml 1 Column II Liquid & Solid Concentration µ Ci/ml 2 Silver (47) Ag-105 Ag-110m Ag-111 1x10 -3 3x10 -4 4x10 -4 Sodium (11) Na-24 2x10 -3 Strontium (38) Sr-85 Sr-89 Sr-91 Sr-92 1x10 -3 1x10 -4 7x10 -4 7x10 -4 Sulfur (16) S-35 9x10 -8 6x10 -4 Tantalum (73) Ta-182 4x10 -4 Technetium (43) Tc-96m Tc-96 1x10 -1 1x10 -3 Tellurium (52) Te-125m Te-127m Te-127 Te-129m Te-131m Te-132 2x10 -3 6x10 -4 3x10 -3 3x10 -4 6x10 -4 3x10 -4 Terbium (65) Tb-160 4x10 -4 Thallium (81) Tl-200 Tl-201 Tl-202 Tl-204 4x10 -3 3x10 -3 1x10 -3 1x10 -3 Thulium (69) Tm-170 Tm-171 5x10 -4 5x10 -3 Tin (50) Sn-113 Sn-125 9x10 -4 2x10 -4 Tungsten (Wolfram) (74) W-181 W-187 4x10 -3 7x10 -4 Vanadium (23) V-48 3x10 -4 Xenon (54) Xe-131m Xe-133 Xe-135 4x10 -6 3x10 -6 1x10 -6 Ytterbium (70) Yb-175 1x10 -3 __________ 1 Values are given in Column I only for those materials normally used as gases. 2 µ C1/gm for solids. Element (atomic number) Isotope Column I Gas Concentration ì Ci/ml 1 Column II Liquid & Solid Concentration ì Ci/ml 2 Yttrium (39) Y-90 Y-91m Y-91 Y-92 Y-93 2x10 -4 3x10 -2 3x10 -4 6x10 -4 3x10 -4 Zinc (30) Zn-65 Zn-69m Zn-69 1x10 -3 7x10 -4 2x10 2 Zirconium (40) Zr-95 Zr-97 6x10 -4 2x10 -4 Beta and/or gamma emitting radioactive material not listed above with half-life less than 3 years 1x10 -10 1x10 -6 NOTE 1: Many radioisotopes disintegrate into isotopes which are also radioactive. In expressing the concentrations in Schedule A the activity stated is that of the parent isotope and takes into account the daughters. NOTE 2: For purposes of ARM 37.14.506 where there is involved a combination of isotopes, the limit for the combination should be derived as follows: determine for each isotope in the product the ratio between the concentration present in the product and the exempt concentration established in Schedule A for the specific isotope when not in combination. The sum of such ratios may not exceed "1" (i.e., unity) . EXAMPLE: Concentration of Isotope A in Product + Exempt concentration of Isotope A Concentration of Isotope B in Product # 1 Exempt concentration of Isotope B __________ 1 Values are given in Column I only for those materials normally used as gases. 2 μ C1/gm for solids. SCHEDULE B EXEMPT QUANTITIES Radioactive Material Microcuries Antimony-122 (Sb 122) 100 Antimony-124 (Sb 124) 10 Antimony-125 (Sb 125) 10 Arsenic-73 (As 73) 100 Arsenic-74 (As 74) 10 Arsenic-76 (As 76) 10 Arsenic-77 (As 77) 100 Barium-131 (Ba 131) 10 Barium-133 (Ba 133) 10 Barium-140 (Ba 140) 10 Bismuth-210 (Bi 210) 1 Bromine-82 (Br 82) 10 Cadmium-109 (Cd 109) 10 Cadmium-115m (Cd 115m) 10 Cadmium-115 (Cd 115) 100 Calcium-45 (Ca 45) 10 Calcium-47 (Ca 47) 10 Carbon-14 (C 14) 100 Cerium-141 (Ce 141) 100 Cerium-143 (Ce 143) 100 Cerium-144 (Ce 144) 1 Cesium-129 (Cs 129) 100 Cesium-131 (Cs 131) 1,000 Cesium-134m (Cs 134m) 100 Cesium-134 (Cs 134) 1 Cesium-135 (Cs 135) 10 Cesium-136 (Cs 136) 10 Cesium-137 (Cs 137) 10 Chlorine-36 (Cl 36) 10 Chlorine-38 (Cl 38) 10 Chromium-51 (Cr 51) 1,000 Cobalt-57 (Co 57) 100 Cobalt-58m (Co 58m) 10 Cobalt-58 (Co 58) 10 Cobalt-60 (Co 60) 1 Copper-64 (Cu 64) 100 Dysprosium-165 (Dy 165) 10 Dysprosium-166 (Dy 166) 100 Erbium-169 (Er 169) 100 Erbium-171 (Er 171) 100 Europium-152 (Eu 152)9.2h 100 Europium-152 (Eu 152)13 yr 1 Europium-154 (Eu 154) 1 Radioactive Material Microcuries Europium-155 (Eu 155) 10 Fluorine-18 (F 18) 1,000 Gadolinium-153 (Gd 153) 10 Gadolinium-159 (Gd 159) 100 Gallium-67 (Ga 67) 100 Gallium-72 (Ga 72) 10 Germanium-71 (Ge 71) 100 Gold-198 (Au 198) 100 Gold-199 (Au 199) 100 Hafnium-181 (Hf 181) 10 Holmium-166 (Ho 166) 100 Hydrogen-3 (H 3) 1,000 Indium-111 (In 111) 100 Indium-113m (In 113m) 100 Indium-114m (In 114m) 10 Indium-115m (In 115m) 100 Indium-115 (In 115) 10 Iodine-123 (I 123) 100 Iodine-125 (I 125) 1 Iodine-126 (I 126) 1 Iodine-129 (I 129) 0.1 Iodine-131 (I 131) 1 Iodine-132 (I 132) 10 Iodine-133 (I 133) 1 Iodine-134 (I 134) 10 Iodine-135 (I 135) 10 Iridium-192 (Ir 192) 10 Iridium-194 (Ir 194) 100 Iron-52 (Fe 52) 10 Iron-55 (Fe 55) 100 Iron-59 (Fe 59) 10 Krypton-85 (Kr 85) 100 Krypton-87 (Kr 87) 10 Lanthanum-140 (La 140) 10 Lutetium-177 (Lu 177) 100 Manganese-52 (Mn 52) 10 Manganese-54 (Mn 54) 10 Manganese-56 (Mn 56) 10 Mercury-197m (Hg 197m) 100 Mercury-197 (Hg 197) 100 Mercury-203 (Hg 203) 10 Molybdenum-99 (Mo 99) 100 Neodymium-147 (Nd 147) 100 Neodymium-149 (Nd 149) 100 Nickel-59 (Ni 59) 100 Nickel-63 (Ni 63) 10 Nickel-65 (Ni 65) 100 Niobium-93m (Nb 93m) 10 Radioactive Material Microcuries Niobium-95 (Nb 95) 10 Niobium-97 (Nb 97) 10 Osmium-185 (Os 185) 10 Osmium-191m (Os 191m) 100 Osmium-191 (Os 191) 100 Osmium-193 (Os 193) 100 Palladium-103 (Pd 103) 100 Palladium-109 (Pd 109) 100 Phosphorus-32 (P 32) 10 Platinum-191 (Pt 191) 100 Platinum-193m (Pt 193m) 100 Platinum-193 (Pt 193) 100 Platinum-197m (Pt 197m) 100 Platinum-197 (Pt 197) 100 Polonium-210 (Po 210) 0.1 Potassium-42 (K 42) 10 Potassium-43 (K 43) 10 Praseodymium-142 (Pr 142) 100 Praseodymium-143 (Pr 143) 100 Promethium-147 (Pm 147) 10 Promethium-149 (Pm 149) 10 Radium-226 (Ra 226) 0.1 Rhenium-186 (Re 186) 100 Rhenium-188 (Re 188) 100 Rhodium-103m (Rh 103m) 100 Rhodium-105 (Rh 105) 100 Rubidium-81 (Rb 81) 10 Rubidium-86 (Rb 86) 10 Rubidium-87 (Rb 87) 10 Ruthenium-97 (Ru 97) 100 Ruthenium-103 (Ru 103) 10 Ruthenium-105 (Ru 105) 10 Ruthenium-106 (Ru 106) 1 Samarium-151 (Sm 151) 10 Samarium-153 (Sm 153) 100 Scandium-46 (Sc 46) 10 Scandium-47 (Sc 47) 100 Scandium-48 (Sc 48) 10 Selenium-75 (Se 75) 10 Silicon-31 (Si 31) 100 Silver-105 (Ag 105) 10 Silver-110m (Ag 110m) 1 Silver-111 (Ag 111) 100 Sodium-22 (Na 22) 10 Sodium-24 (Na 24) 10 Strontium-85 (Sr 85) 10 Strontium-89 (Sr 89) 1 Radioactive Material Microcuries Strontium-90 (Sr 90) 0.1 Strontium-91 (Sr 91) 10 Strontium-92 (Sr 92) 10 Sulphur-35 (S 35) 100 Tantalum-182 (Ta 182) 10 Technetium-96 (Tc 96) 10 Technetium-97m (Tc 97m) 100 Technetium-97 (Tc 97) 100 Technetium-99m (Tc 99m) 100 Technetium-99 (Tc 99) 10 Tellurium-125m (Te 125m) 10 Tellurium-127m (Te 127m) 10 Tellurium-127 (Te 127) 100 Tellurium-129m (Te 129m) 10 Tellurium-129 (Te 129) 100 Tellurium-131m (Te 131m) 10 Tellurium-132 (Te 132) 10 Terbium-160 (Tb 160) 10 Thallium-200 (Tl 200) 100 Thallium-201 (Tl 201) 100 Thallium-202 (Tl 202) 100 Thallium-204 (Tl 204) 10 Thulium-170 (Tm 170) 10 Thulium-171 (Tm 171) 10 Tin-113 (Sn 113) 10 Tin-125 (Sn 125) 10 Tungsten-181 (W 181) 10 Tungsten-185 (W 185) 10 Tungsten-187 (W 187) 100 Vanadium-48 (V 48) 10 Xenon-131m (Xe 131m) 1,000 Xenon-133 (Xe 133) 100 Xenon-135 (Xe 135) 100 Ytterbium-175 (Yb 175) 100 Yttrium-87 (Y 87) 10 Yttrium-90 (Y 90) 10 Yttrium-91 (Y 91) 10 Yttrium-92 (Y 92) 100 Yttrium-93 (Y 93) 100 Zinc-65 (Zn 65) 10 Zinc-69m (Zn 69m) 100 Zinc-69 (Zn 69) 1,000 Zirconium-93 (Zr 93) 10 Zirconium-95 (Zr 95) 10 Zirconium-97 (Zr 97) 10 Any radioactive material not listed above other than alpha emitting radioactive material 0.1 Note 1: For purposes of ARM 37.14.521 where there is involved a combination of isotopes, the limit for the combination should be derived as follows: Determine the amount of each isotope possessed and 1,000 times the amount in Schedule B for each of those isotopes when not in combination. The sum of the ratios of those quantities may not exceed 1 (i.e., unity) . Example: Amt. of Isotope A possessed + Amt. of Isotope B possessed < 1 1000 x Schedule B quantity 1000 x Schedule B quantity for Isotope A for Isotope B SCHEDULE C GROUPS OF MEDICAL USES OF RADIOACTIVE MATERIAL Group I. Use of prepared radiopharmaceuticals for certain diagnostic studies involving measurements of uptake, dilution and excretion (does not include uses involving imaging and tumor localizations) (1) Iodine-131 as sodium iodide (Na 131 I) for measurement of thyroid uptake. (2) Iodine-125 as sodium iodide (Na 125 I) for measurement of thyroid uptake. (3) Iodine-131 as iodinated human serum albumin (IHSA) for determination of blood and blood plasma volume and for studies of cardiovascular function and protein turnover. (4) Iodine-125 as iodinated human serum albumin (IHSA) for determination of blood and blood plasma volume and for studies of cardiovascular function and protein turnover. (5) Iodine-131 as labeled rose bengal for liver function studies. (6) Iodine-125 as labeled rose bengal for liver function studies. (7) Iodine-131 as labeled fats or fatty acids for fat absorption studies. (8) Iodine-125 as labeled fats or fatty acids for fat absorption studies. (9) Iodine-131 as labeled iodopyracet, sodium iodohippurate, sodium diatrizoate, diatrizoate methylglucamine, sodium diprotrizoate, sodium acetrizoete, or sodium iothalamate for kidney function studies. (10) Iodine-125 as labeled iodopyracet, sodium iodohippurate, sodium diatrizoate, distrizoate methylglucamine, sodium diprotrizoate, sodium acetrizoate, or sodium iothalamate for kidney function studies. (11) Cobalt-57 as labeled cyanocobalamin for intestinal absorption studies. (12) Cobalt-58 as labeled cyanocobalamin for intestinal absorption studies. (13) Cobalt-60 as labeled cyanocobalamin for intestinal absorption studies. (14) Chromium-51 as sodium chromate for determination of red blood cell volume and studies of red blood cell survival time and gastrointestinal blood loss. (15) Chromium-51 as labeled human serum albumin for gastrointestinal protein loss studies. (16) Iron-59 as chloride, citrate, or sulfate for iron turnover studies. (17) Potassium-42 as chloride for potassium space determinations. (18) Sodium-24 as chloride for sodium space determinations. (19) Technetium-99m as pertechnetate for blood flow studies. (20) Mercury as chlormerodrin for kidney function studies. (21) Any radioactive material in a radiopharmaceutical and for a diagnostic use involving measurements of uptake, dilution, or excretion for which a "Notice of Claimed Investigational Exemption for a New Drug" (IND) has been accepted by the Food and Drug Administration (FDA) . (22) Iodine-123 as sodium iodide (NaI) for measurement of thyroid uptake. Group II. Use of prepared radiopharmaceuticals for diagnostic studies involving imaging and tumor localizations (1) Iodine-131 as sodium iodide for thyroid imaging. (2) Iodine-125 as sodium iodide for thyroid imaging. (3) Iodine-131 as iodinated human serum albumin (IHSA) for brain tumor localizations and cardiac imaging. (4) Iodine-131 as macroaggregated iodinated human serum albumin for lung imaging. (5) Iodine-131 as colloidal (microaggregated) iodinated human serum albumin for liver imaging. (6) Iodine-131 as labeled rose bengal for liver imaging. (7) Iodine-131 as iodopyracet, sodium iodohippurate, sodium diatrizoate, diatrizoate methyglucamine, sodium diprotrizoate, or sodium acetrizoate for kidney imaging. (8) Iodine-131 as sodium iodipamide for cardiac imaging. (9) Iodine-131 as iodinated human serum albumin (IHSA) for placenta localization. (10) Chromium-51 as sodium chromate for spleen imaging. (11) Chromium-51 as labeled human serum albumin for placenta localization. (12) Gold-198 in colloidal form for liver imaging. (13) Mercury-197 as labeled chlormerodrin for kidney and brain imaging. (14) Mercury-203 as labeled chlormerodrin for brain imaging. (15) Selenium-75 as labeled selenomethionine for pancreas imaging. (16) Strontium-85 as nitrate or chloride for bone imaging in patients with suspected or diagnosed cancer. (17) Technetium-99m as pertechnetate for brain imaging. (18) Technetium-99m as pertechnetate for thyroid imaging. (19) Technetium-99m as pertechnetate for salivary gland imaging. (20) Technetium-99m as pertechnetate for blood pool imaging, including placenta localization. (21) Technetium-99m as labeled sulfur colloid for liver, spleen, and bone marrow imaging. (22) Technetium-99m as labeled macroaggregated human serum albumin for lung imaging. (23) Any radioactive material in a radiopharmaceutical prepared from a reagent kit listed in (4) of Group III. (24) Any radioactive material in a radiopharmaceutical and for a diagnostic use involving imaging for which a "Notice of Claimed Investigational Exemption for a New Drug" (IND) has been accepted by the Food and Drug Administration (FDA) . (25) Fluorine-18 in solution for bone imaging. (26) Strontium-87m for bone imaging. (27) Iodine-125 as fibrinogen for detection and monitoring of developing deep vein thrombosis. (28) Ytterbium-169 as labeled diethylenetriamine-pentaacetic acid (DTPA) for cistornography. (29) Iodine-123 as sodium iodide (NaI) for thyroid imaging. (30) Indium-113m as chloride for blood pool imaging, including placenta localization. Group III. Use of generators and reagent kits for the preparation and use of radiopharmaceuticals containing radioactive material for certain diagnostic uses (1) Molybdenum-99/technetium-99m generators for the elution of technetium-99m as pertechnetate for: (i) brain imaging; (ii) thyroid imaging; (iii) salivary gland imaging; (iv) blood pool imaging including placenta localization; (v) blood flow studies; and (vi) use with reagent kits for preparation and use of radiopharmaceuticals containing technetium-99m as provided in (4) and (5) of this group. (2) Yttrium-87/strontium-87m generators for the elution of strontium-87m for bone imaging. (3) Technetium-99m as pertechnetate for use with reagent kits for preparation and use of radiopharmaceuticals containing technetium-99m as provided in (4) and (5) of this group. (4) Reagent kits for preparation of technetium-99m labeled: (i) sulfur colloid for liver, spleen, and bone marrow imaging; (ii) iron-ascorbate-diethylenetriaminepentaacetic acid complex for kidney imaging; (iii) diethylenetriaminepentaacetic acid (Sn) for kidney imaging and kidney function studies; (iv) diethylenetriaminepentaacetic acid (Sn) for brain imaging; (v) human serum albumin microspheres for lung imaging; (vi) polyphosphates for bone imaging; (vii) macroaggregated human serum albumin for lung imaging; (viii) distannous etidronate complex for bone imaging; (ix) stannous pyrophosphate for bone and cardiac imaging; (x) human serum albumin for heart blood pool imaging; and (xi) medronate sodium for bone imaging. (5) Any generator or reagent kit for preparation and diagnostic use of a radiopharmaceutical containing radioactive material for which generator or reagent kit a "Notice of Claimed Investigational Exemption for a New Drug" (IND) has been accepted by the Food and Drug Administration (FDA) . (6) Tin-113/indium-113m generators for the elution of indium-113m as chloride for: (i) blood pool imaging including placenta localization. Group IV. Use of prepared radiopharmaceuticals for certain therapeutic uses that do not normally require hospitalization for purposes of radiation safety (1) Iodine-131 as iodide for treatment of hyperthyroidism and cardiac dysfunction. (2) Phosphorus-32 as soluble phosphate for treatment of polycythemia vera, leukemia, and bone metastases. (3) Phosphorus-32 as colloidal chromic phosphate for intracavitary treatment of malignant effusions. (4) Any radioactive material in a radiopharmaceutical and for a therapeutic use not normally requiring hospitalization for purposes of radiation safety for which a "Notice of Claimed Investigational Exemption for a New Drug" (IND) has been accepted by the Food and Drug Administration (FDA) . Group V. Use of prepared radiopharmaceuticals for certain therapeutic uses that normally require hospitalization for purposes of radiation safety (1) Gold-198 as colloid for intracavitary treatment of malignant effusions. (2) Iodine-131 as iodide for treatment of thyroid carcinoma. (3) Any radioactive material in a radiopharmaceutical and for a therapeutic use normally requiring hospitalization for radiation safety reasons for which a "Notice of Claimed Investigational Exemption for a New Drug" (IND) has been accepted by the Food and Drug Administration (FDA) . Group VI. Use of sources and devices containing radioactive material for certain medical uses (1) Americium-241 as a sealed source in a device for bone mineral analysis. (2) Cesium-137 encased in needles and applicator cells for topical, interstitial, and intracavitary treatment of cancer. (3) Cobalt-60 encased in needles and applicator cells for topical, interstitial, and intracavitary treatment of cancer. (4) Gold-198 as seeds for interstitial treatment of cancer. (5) Iodine-125 as a sealed source in a device for bone mineral analysis. (6) Iridium-192 as seeds encased in nylon ribbon for interstitial treatment of cancer. (7) Strontium-90 sealed in an applicator for treatment of superficial eye conditions. (8) Radon-222 as seeds for topical, interstitial, and intracavitary treatment of cancer. (9) Radium-226 as a sealed source for topical, interstitial, and intracavitary treatment of cancer. (10) Iodine-125 as seeds for interstitial treatment of cancer. SCHEDULE D LIMITS FOR BROAD LICENCES Radioactive Material Col. I curies Col. II curies Antimony-122 1 0.01 Antimony-124 1 0.01 Antimony-125 1 0.01 Arsenic-73 10 0.1 Arsenic-74 1 0.01 Arsenic-76 1 0.01 Arsenic-77 10 0.1 Barium-131 10 0.1 Barium-140 1 0.01 Beryllium-7 10 0.1 Bismuth-210 0.1 0.001 Bromine-82 10 0.1 Cadmium-109 1 0.01 Cadmium-115m 1 0.01 Cadmium-115 10 0.1 Calcium-45 1 0.01 Calcium-47 10 0.1 Carbon-14 100 1. Cerium-141 10 0.1 Cerium-143 10 0.1 Cerium-144 0.1 0.001 Cesium-131 100 1. Cesium-134m 100 1. Cesium-134 0.1 0.001 Cesium-135 1 0.01 Cesium-136 10 0.1 Cesium-137 0.1 0.001 Chlorine-36 1 0.01 Chlorine-38 100 1. Chromium-51 100 1. Cobalt-57 10 0.1 Cobalt-58m 100 1. Cobalt-58 1 0.01 Cobalt-60 0.1 0.001 Copper-64 10 0.1 Dysprosium-165 100 1. Dysprosium-166 10 0.1 Erbium-169 10 0.1 Erbium-171 10 0.1 Europium-152 (9.2h) 10 0.1 Europium-152 (13 y) 0.1 0.001 Europium-154 0.1 0.001 Europium-155 1 0.01 Fluorine-18 100 1. Radioactive Material Col. I curies Col. II curies Gadolinium-153 1 0.01 Gadolinium-159 10 0.1 Gallium-72 10 0.1 Germanium-71 100 1. Gold-198 10 0.1 Gold-199 10 0.1 Hafnium-181 1 0.01 Holmium-166 10 0.1 Hydrogen-3 100 1. Indium-113m 100 1. Indium-114m 1 0.01 Indium-115m 100 1. Indium-115 1 0.01 Iodine-125 0.1 0.001 Iodine-126 0.1 0.001 Iodine-129 0.1 0.001 Iodine-131 0.1 0.001 Iodine-132 10 0.1 Iodine-133 1 0.01 Iodine-134 10 0.1 Iodine-135 1 0.01 Iridium-192 1 0.01 Iridium-194 10 0.1 Iron-55 10 0.1 Iron-59 1 0.01 Krypton-85 100 1. Krypton-87 10 0.1 Lanthanum-140 1 0.01 Lutetium-177 10 0.1 Manganese-52 1 0.01 Manganese-54 1 0.01 Manganese-56 10 0.1 Mercury-197m 10 0.1 Mercury-197 10 0.1 Mercury-203 1 0.01 Molybdenum-99 10 0.1 Neodymium-147 10 0.1 Neodymium-149 10 0.1 Nickel-59 10 0.1 Nickel-63 1 0.01 Nickel-65 10 0.1 Niobium-93m 1 0.01 Niobium-95 1 0.01 Niobium-97 100 1. Osmium-185 1 0.01 Osmium-191m 100 1. Osmium-191 10 0.1 Radioactive Material Col. I curies Col. II curies Osmium-193 10 0.1 Palladium-103 10 0.1 Palladium-109 10 0.1 Phosphorus-32 1 0.01 Platinum-191 10 0.1 Platinum-193m 100 1. Platinum-193 10 0.1 Platinum-197m 100 1. Platinum-197 10 0.1 Polonium-210 0.1 0.0001 Potassium-42 1 0.01 Praseodymium-142 10 0.1 Praseodymium-143 10 0.1 Promethium-147 1 0.01 Promethium-149 10 0.1 Radium-226 0.01 0.0001 Rhenium-186 10 0.1 Rhenium-188 10 0.1 Rhodium-103m 1,000 10. Rhodium-105 10 0.1 Rubidium-86 1 0.01 Rubidium-87 1 0.01 Ruthenium-97 100 1. Ruthenium-103 1 0.01 Ruthenium-105 10 0.1 Ruthenium-106 0.1 0.001 Samarium-151 1 0.01 Samarium-153 10 0.1 Scandium-46 1 0.01 Scandium-47 10 0.1 Scandium-48 1 0.01 Selenium-75 1 0.01 Silicon-31 10 0.1 Silver-105 1 0.01 Silver-110m 0.1 0.001 Silver-111 10 0.1 Sodium-22 0.1 0.001 Sodium-24 1 0.01 Strontium-85m 1,000 10. Strontium-85 1 0.01 Strontium-89 1 0.01 Strontium-90 0.01 0.0001 Strontium-91 10 0.1 Strontium-92 10 0.1 Sulphur-35 10 0.1 Tantalum-182 1 0.01 Technetium-96 10 0.1 Technetium-97m 10 0.1 Radioactive Material Col. I curies Col. II curies Technetium-97 10 0.1 Technetium-99m 100 1. Technetium-99 1 0.01 Tellurium-125m 1 0.01 Tellurium-127m 1 0.01 Tellurium-127 10 0.1 Tellurium-129m 1 0.01 Tellurium-129 100 1. Tellurium-131m 10 0.1 Tellurium-132 1 0.01 Terbium-160 1 0.01 Thallium-200 10 0.1 Thallium-201 10 0.1 Thallium-202 10 0.1 Thallium-204 1 0.01 Thulium-170 1 0.01 Thulium-171 1 0.01 Tin-113 1 0.01 Tin-125 1 0.01 Tungsten-181 1 0.01 Tungsten-185 1 0.01 Tungsten-187 10 0.1 Vanadium-48 1 0.01 Xenon-131m 1,000 10. Xenon-133 100 1. Xenon-135 100 1. Ytterbium-175 10 0.1 Yttrium-90 1 0.01 Yttrium-91 1 0.01 Yttrium-92 10 0.1 Yttrium-93 1 0.01 Zinc-65 1 0.01 Zinc-69m 10 0.1 Zinc-69 100 1. Zirconium-93 1 0.01 Zirconium-95 1 0.01 Zirconium-97 1 0.01 Any radioactive material other than source material, special nuclear material, or alpha emitting radioactive material not listed above. 0.1 0.001